Advancing Medical Applications of Cancer Nanotechnology: Highlighting Two Decades of the NCI'S Nanotechnology Characterization Laboratory Service to the Research Community

Rachael M. Crist; Yechezkel Barenholz; Ahuva Cern; Kate N. Clark; Pieter R. Cullis; Cheryl Dean; Neil Desai; Mauro Ferrari; Matthieu Germain; Carmen A. Giacomantonio; Emma Grabarnik; Piotr Grodzinski; Atara Hod; Barry E. Kennedy; Ruvanthi N. Kularatne; Glen S. Kwon; Emmanuel Loeb; Erin B. Noftall; Len Pagliaro; Morteza Rasoulianboroujeni; Alexander Roth; Darren Rowles; Kulbir Singh; Nicole F. Steinmetz; Zhanna Yehtina; Yao Zhang; Daniel Zilbersheid; Jeffrey D. Clogston; Stephan T. Stern; Marina A. Dobrovolskaia

doi:10.1002/wnan.70020

Advancing Medical Applications of Cancer Nanotechnology: Highlighting Two Decades of the NCI'S Nanotechnology Characterization Laboratory Service to the Research Community

Rachael M. Crist^*
, Yechezkel Barenholz
, Ahuva Cern
, Kate N. Clark
, Pieter R. Cullis
, Cheryl Dean
, Neil Desai
, Mauro Ferrari
, Matthieu Germain
, Carmen A. Giacomantonio
, Emma Grabarnik
, Piotr Grodzinski
, Atara Hod
, Barry E. Kennedy
, Ruvanthi N. Kularatne
, Glen S. Kwon
, Emmanuel Loeb
, Erin B. Noftall
, Len Pagliaro
, Morteza Rasoulianboroujeni

Alexander Roth, Darren Rowles, Kulbir Singh, Nicole F. Steinmetz, Zhanna Yehtina, Yao Zhang, Daniel Zilbersheid, Jeffrey D. Clogston^*, Stephan T. Stern^*, Marina A. Dobrovolskaia^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

The Nanotechnology Characterization Laboratory (NCL) is a US federally funded resource providing characterization and expertise to the cancer nanomedicine research community. Founded as a formal partnership among the US National Cancer Institute (NCI), the US Food and Drug Administration (FDA), and the US National Institute of Standards and Technology (NIST), the NCL has spent two decades developing a one-of-a-kind service with broad multidisciplinary expertise to meet the needs of a rapidly evolving drug development field. To mark the 20th anniversary of the lab's founding, the NCL hosted a symposium to highlight the achievements of the cancer nanomedicine field, showcase novel, next-generation nanotechnology research, and discuss future priorities to enable continued growth in combating cancer and the complexities associated with treating a disease that continues to take millions of lives annually. The discussion topics from this event are summarized.

Original language	English
Article number	e70020
Journal	Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
Volume	17
Issue number	3
DOIs	https://doi.org/10.1002/wnan.70020
State	Published - 1 May 2025

Bibliographical note

Publisher Copyright:
© 2025 The Author(s). WIREs Nanomedicine and Nanobiotechnology published by Wiley Periodicals LLC. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

cancer
nanomedicine
nanotechnology

Access to Document

10.1002/wnan.70020

Cite this

Crist, R. M., Barenholz, Y., Cern, A., Clark, K. N., Cullis, P. R., Dean, C., Desai, N., Ferrari, M., Germain, M., Giacomantonio, C. A., Grabarnik, E., Grodzinski, P., Hod, A., Kennedy, B. E., Kularatne, R. N., Kwon, G. S., Loeb, E., Noftall, E. B., Pagliaro, L., ... Dobrovolskaia, M. A. (2025). Advancing Medical Applications of Cancer Nanotechnology: Highlighting Two Decades of the NCI'S Nanotechnology Characterization Laboratory Service to the Research Community. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 17(3), Article e70020. https://doi.org/10.1002/wnan.70020

@article{aa9354425d704054b4d45025951427bf,

title = "Advancing Medical Applications of Cancer Nanotechnology: Highlighting Two Decades of the NCI'S Nanotechnology Characterization Laboratory Service to the Research Community",

abstract = "The Nanotechnology Characterization Laboratory (NCL) is a US federally funded resource providing characterization and expertise to the cancer nanomedicine research community. Founded as a formal partnership among the US National Cancer Institute (NCI), the US Food and Drug Administration (FDA), and the US National Institute of Standards and Technology (NIST), the NCL has spent two decades developing a one-of-a-kind service with broad multidisciplinary expertise to meet the needs of a rapidly evolving drug development field. To mark the 20th anniversary of the lab's founding, the NCL hosted a symposium to highlight the achievements of the cancer nanomedicine field, showcase novel, next-generation nanotechnology research, and discuss future priorities to enable continued growth in combating cancer and the complexities associated with treating a disease that continues to take millions of lives annually. The discussion topics from this event are summarized.",

keywords = "cancer, nanomedicine, nanotechnology",

author = "Crist, \{Rachael M.\} and Yechezkel Barenholz and Ahuva Cern and Clark, \{Kate N.\} and Cullis, \{Pieter R.\} and Cheryl Dean and Neil Desai and Mauro Ferrari and Matthieu Germain and Giacomantonio, \{Carmen A.\} and Emma Grabarnik and Piotr Grodzinski and Atara Hod and Kennedy, \{Barry E.\} and Kularatne, \{Ruvanthi N.\} and Kwon, \{Glen S.\} and Emmanuel Loeb and Noftall, \{Erin B.\} and Len Pagliaro and Morteza Rasoulianboroujeni and Alexander Roth and Darren Rowles and Kulbir Singh and Steinmetz, \{Nicole F.\} and Zhanna Yehtina and Yao Zhang and Daniel Zilbersheid and Clogston, \{Jeffrey D.\} and Stern, \{Stephan T.\} and Dobrovolskaia, \{Marina A.\}",

note = "Publisher Copyright: {\textcopyright} 2025 The Author(s). WIREs Nanomedicine and Nanobiotechnology published by Wiley Periodicals LLC. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.",

year = "2025",

month = may,

day = "1",

doi = "10.1002/wnan.70020",

language = "אנגלית",

volume = "17",

journal = "Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology",

issn = "1939-5116",

publisher = "John Wiley \& Sons Inc.",

number = "3",

}

Crist, RM, Barenholz, Y , Cern, A, Clark, KN, Cullis, PR, Dean, C, Desai, N, Ferrari, M, Germain, M, Giacomantonio, CA, Grabarnik, E, Grodzinski, P, Hod, A, Kennedy, BE, Kularatne, RN, Kwon, GS, Loeb, E, Noftall, EB, Pagliaro, L, Rasoulianboroujeni, M, Roth, A, Rowles, D, Singh, K, Steinmetz, NF, Yehtina, Z, Zhang, Y, Zilbersheid, D, Clogston, JD, Stern, ST & Dobrovolskaia, MA 2025, 'Advancing Medical Applications of Cancer Nanotechnology: Highlighting Two Decades of the NCI'S Nanotechnology Characterization Laboratory Service to the Research Community', Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, vol. 17, no. 3, e70020. https://doi.org/10.1002/wnan.70020

Advancing Medical Applications of Cancer Nanotechnology: Highlighting Two Decades of the NCI'S Nanotechnology Characterization Laboratory Service to the Research Community. / Crist, Rachael M.; Barenholz, Yechezkel ; Cern, Ahuva et al.
In: Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Vol. 17, No. 3, e70020, 01.05.2025.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Advancing Medical Applications of Cancer Nanotechnology

T2 - Highlighting Two Decades of the NCI'S Nanotechnology Characterization Laboratory Service to the Research Community

AU - Crist, Rachael M.

AU - Barenholz, Yechezkel

AU - Cern, Ahuva

AU - Clark, Kate N.

AU - Cullis, Pieter R.

AU - Dean, Cheryl

AU - Desai, Neil

AU - Ferrari, Mauro

AU - Germain, Matthieu

AU - Giacomantonio, Carmen A.

AU - Grabarnik, Emma

AU - Grodzinski, Piotr

AU - Hod, Atara

AU - Kennedy, Barry E.

AU - Kularatne, Ruvanthi N.

AU - Kwon, Glen S.

AU - Loeb, Emmanuel

AU - Noftall, Erin B.

AU - Pagliaro, Len

AU - Rasoulianboroujeni, Morteza

AU - Roth, Alexander

AU - Rowles, Darren

AU - Singh, Kulbir

AU - Steinmetz, Nicole F.

AU - Yehtina, Zhanna

AU - Zhang, Yao

AU - Zilbersheid, Daniel

AU - Clogston, Jeffrey D.

AU - Stern, Stephan T.

AU - Dobrovolskaia, Marina A.

N1 - Publisher Copyright: © 2025 The Author(s). WIREs Nanomedicine and Nanobiotechnology published by Wiley Periodicals LLC. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.

PY - 2025/5/1

Y1 - 2025/5/1

N2 - The Nanotechnology Characterization Laboratory (NCL) is a US federally funded resource providing characterization and expertise to the cancer nanomedicine research community. Founded as a formal partnership among the US National Cancer Institute (NCI), the US Food and Drug Administration (FDA), and the US National Institute of Standards and Technology (NIST), the NCL has spent two decades developing a one-of-a-kind service with broad multidisciplinary expertise to meet the needs of a rapidly evolving drug development field. To mark the 20th anniversary of the lab's founding, the NCL hosted a symposium to highlight the achievements of the cancer nanomedicine field, showcase novel, next-generation nanotechnology research, and discuss future priorities to enable continued growth in combating cancer and the complexities associated with treating a disease that continues to take millions of lives annually. The discussion topics from this event are summarized.

AB - The Nanotechnology Characterization Laboratory (NCL) is a US federally funded resource providing characterization and expertise to the cancer nanomedicine research community. Founded as a formal partnership among the US National Cancer Institute (NCI), the US Food and Drug Administration (FDA), and the US National Institute of Standards and Technology (NIST), the NCL has spent two decades developing a one-of-a-kind service with broad multidisciplinary expertise to meet the needs of a rapidly evolving drug development field. To mark the 20th anniversary of the lab's founding, the NCL hosted a symposium to highlight the achievements of the cancer nanomedicine field, showcase novel, next-generation nanotechnology research, and discuss future priorities to enable continued growth in combating cancer and the complexities associated with treating a disease that continues to take millions of lives annually. The discussion topics from this event are summarized.

KW - cancer

KW - nanomedicine

KW - nanotechnology

UR - https://www.scopus.com/pages/publications/105007635386

U2 - 10.1002/wnan.70020

DO - 10.1002/wnan.70020

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 40458962

AN - SCOPUS:105007635386

SN - 1939-5116

VL - 17

JO - Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

JF - Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

IS - 3

M1 - e70020

ER -

Advancing Medical Applications of Cancer Nanotechnology: Highlighting Two Decades of the NCI'S Nanotechnology Characterization Laboratory Service to the Research Community

Abstract

Bibliographical note

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this